CARLSBAD -
EOS Catalyst builds on the already unprecedented functionality of the EOS imaging platform with automated alignment and surgical planning capabilities.
'EOS is foundational to ATEC's mission to revolutionize spine surgery,' said
Dr. Vedat Deviren, MD, Spine Surgeon and Professor of Orthopaedic Surgery at the
About EOS Catalyst
EOS Catalyst integrates information and data collection throughout the surgical experience through a cloud-based platform. The initial Catalyst release will include the following: Automatic, quantified alignment assessment. AI-driven alignment information with level-labeling and color-coded patient benchmarking to normative values will be available minutes after an EOS exam.
3D-surgical planning. 3D-modelling of the patient's spine and alignment will more easily designate patients for surgery.
Patient-specific pre-bent rods. Seamless ordering, approval and delivery of pre-bent rods for short and long construct surgery will improve intra-operative sagittal correction.
Intra-operative reconciliation. Full-spine intra-operative measurements of key coronal and sagittal parameters throughout surgery will inform objective comparisons to the pre-operative plan and enable exportation for post-operative analysis.
The Company expects the Catalyst platform, which is currently under limited evaluation, to be released in mid-2024.
About ATEC
ATEC, through its wholly owned subsidiaries,
Forward Looking Statements
This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described therein. Forward-looking statements include references to the Company's expectations with respect to future revenue and growth and planned commercial launches, introductions, integration, regulatory submissions or clearances. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to: failure to achieve acceptance of the Company's products by the surgeon community and the uncertainty of success in developing new products or products currently in the pipeline. The words 'believe,' 'will,' 'should,' 'expect,' 'intend,' 'estimate,' 'look forward' and 'anticipate,' and variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. A further list and description of these and other factors, risks and uncertainties can be found in the Company's most recent annual report, and any subsequent quarterly and current reports, filed with the
Contact:
Tel: (760) 494-6790
Email: investorrelations@atecspine.com
(C) 2023 Electronic News Publishing, source